Related Experiment Video
Updated: Nov 19, 2025
08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.3K
Precautions for Patients Taking Aromatase Inhibitors
Mary Heery1, Stephen Farley2, Rhett Sparkman2
1Western Connecticut Health Network at The Smilow Family Breast Health Center, Norwalk Hospital, Norwalk, Connecticut.
Journal of the Advanced Practitioner in Oncology
|February 3, 2021
Summary
Aromatase inhibitors effectively treat hormone-sensitive breast cancer in postmenopausal women. Patient education on managing side effects is crucial for treatment adherence.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Aromatase inhibitors are primary treatments for estrogen receptor-positive breast cancer in postmenopausal women.
- Aromatase enzyme is key in estrogen biosynthesis, making its inhibitors effective cancer therapies.
- Clinical trials confirm the benefits of aromatase inhibitors.
Purpose of the Study:
- To highlight the importance of patient education for aromatase inhibitor therapy.
- To address challenges in adherence to aromatase inhibitor treatment.
Main Methods:
- Review of clinical trial data on aromatase inhibitors.
- Analysis of factors affecting patient adherence.
Main Results:
- Aromatase inhibitors demonstrate significant efficacy in breast cancer treatment.
- Patient adherence can be hindered by drug interactions and side effects.
Conclusions:
- Comprehensive patient education is vital for managing adverse effects and improving adherence.
- Effective management strategies are essential for successful aromatase inhibitor therapy.
Related Concept Videos
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
445
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
445
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.3K
01:25Aortic Regurgitation III: Medical Management
173
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
173
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
253
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
253
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
667
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
667
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.0K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.0K